This study examines whether subretinal transplantation of a human retinal pigment epithelial cell line (ARPE19) or human Schwann cells early in the course of degeneration can limit the loss of visual acuity that normally occurs in dystrophic Royal College of Surgeons (RCS) rats as they age. The acuity of both transplanted groups was significantly better than controls at all ages tested, though the rescue profile of each cell type was unique. These data indicate that the transplantation of cells with very different phenotypes can be used to limit the deterioration of spatial vision in an animal model of retinal degenerative disease.
Introduction
Photoreceptor degeneration due to defects of either the photoreceptors themselves or of the adjacent retinal pigment epithelial (RPE) cell layer constitutes a major cause of blindness worldwide (Berson, Dunn, & Takao, 2002; Fine, Berger, Maguire, & Ho, 2000; Phelan & Bok, 2000) . Studying the causes, consequences and potential treatments for these conditions is aided by the availability of animal models with natural mutations providing phenotypes that are homologous or analogous to those seen in patients (Acland et al., 2001; Aleman et al., 2001; Cao, Li, Steinberg, & Lavail, 2001; DÕCruz et al., 2000; Farber, 1995; LaVail, 1981 LaVail, , 2001 Machida et al., 2000; Ohara, Tauscher, & LaVail, 2001; Olsson et al., 1992; Ren et al., 2001; Rohrer, LaVail, Jones, & Reichardt, 2001; Vollrath et al., 2001) .
Although numerous studies have slowed the progress of photoreceptor degeneration in animal models of retinal degenerative diseases (e.g. Acland et al., 2001; Ali et al., 2000; Li et al., 1998) , very little attention has been paid to how photoreceptor rescue translates into rescue of centrally-mediated visual functions, in particular spatial vision. This is surprising given that progressive loss of vision is the most insidious and debilitating consequence of retinal degeneration, and preventing its decline would be the ultimate measure of a successful treatment.
Recently, we examined how visual acuity deteriorates during the course of retinal degeneration in the RCS rat (McGill, Douglas, Lund, & Prusky, 2004) , an animal in which photoreceptors degenerate as the result of a Mertk mutation (DÕCruz et al., 2000) . The mutation renders RPE cells unable to perform their normal supportive role to the photoreceptors (Chaitin & Hall, 1983; Dowling & Sidman, 1962) resulting in progressive photoreceptor death. We found in these animals that acuity was near normal at one month of age, but that vision declined slowly over subsequent months until blindness was reached by 11 months.
Among the potential treatments for retinal degenerative disease is the subretinal transplantation of cells. One approach has been to provide an alternative RPE cell type to replace the physiological function of defective cells (Lund et al., 2001) . The human-derived RPE cell line, ARPE19, exemplifies many features typical of RPE cells (Kanuga et al., 2002) , and when transplanted into the retina of young RCS rats, slows the progress of photoreceptor loss , the deterioration of retinal sensitivity (Sauve, Girman, Wang, Keegan, & Lund, 2002; Yamamoto, Du, Gouras, & Kjeldbye, 1993) , and the physiological response specificity of single units in the primary visual cortex (Girman, Wang, & Lund, 2003) . Another approach has been to transplant primary cultures of Schwann cells: these have been shown to rescue photoreceptors from degeneration in both RCS rats and rhodopsin knockout mice (Keegan et al., 2003; Lawrence et al., 2000 Lawrence et al., , 2004 and to slow the decline in visual responsiveness (measuring physiological properties in the superior colliculus) and a behavioral parameter (measuring head tracking responses to a rotating drum) in RCS rats (Lawrence et al., 2000) . The rationale of the Schwann cell effect is presumed to lie in the fact that they are known to produce a range of growth factors (Hammarberg et al., 1996; Neuberger & De Vries, 1993) , which have been shown, when introduced into the eye, to protect photoreceptors from degeneration (Carwile, Culbert, Sturdivant, & Kraft, 1998; Faktorovich, Steinberg, Yasumura, Matthes, & LaVail, 1992; Perry, Du, Kjeldbye, & Gouras, 1995) . Until now, there has been no systematic quantitative study, examining spatial vision thresholds in animals with subretinal cell transplants. The object of the present study is to evaluate whether the subretinal transplantation of ARPE19 or human Schwann cells can slow the progressive loss of visual acuity in the RCS rat. If either treatment were successful, it would provide essential validation for using cell-based therapies to treat retinal degenerative disease.
Materials and methods

Animals
Forty-five pigmented dystrophic RCS rats were used in this study. Data from a previous study (McGill et al., 2004) examining acuity using identical testing conditions in non-dystrophic and unoperated dystrophic rats provided background reference material. The animals were housed and handled with the authorization and supervision of the Institutional Animal Care and Use Committee (IACUC) at the University of Utah, and the University of Lethbridge animal care committee. Animals were cared for in accordance with National Institute of Health (NIH) and Canadian Council on Animal Care (CCAC) guidelines.
Animals were housed in isolated rooms with a 12 h dark/light cycle, a constant temperature of 22°C, and where food and water were available ad libitum. All animals were maintained on cyclosporin A, administered in the drinking water (210 mg/l) resulting blood concentration of around 300 lg/l from one day prior to transplantation until they were sacrificed after all behavioral testing was completed.
Transplantation
Two donor cell types were used for transplantation. The first was the extended life human ARPE19 cell line (ATCC; Dunn, Aotaki-Keen, Putkey, & Hjelmeland, 1996) (which was stored in liquid nitrogen prior to removing, culturing and preparing for transplantation as described elsewhere, Lund et al., 2001) . The second was a human Schwann cell culture isolated from organ donors using a methodology described elsewhere (Casella, Bunge, & Wood, 1996) . Two control groups were also used. The first group was a sham operated control in which only vehicle was injected. The second utilized fibroblasts as a control cell type for Schwann cell transplantation, because it is likely that the Schwann cell cultures were contaminated with a small number of fibroblasts. In addition, unoperated non-dystrophic and dystrophic rats used in a previous study (McGill et al., 2004) provided reference material.
The transplantation procedure that was used has been detailed elsewhere (Lawrence et al., 2000; Lund et al., 2001) . Briefly, rats were anesthetized with 2,2,2 tribromoethanol (230 mg/kg) and topical Ophthaine was placed on the eye prior to surgery. The pupil was dilated with tropicamide and the eye was proptosed slightly using a thread. Donor cells were plated in a poly-L L-lysine-coated flask in a medium including DMEM containing 10% fetal bovine serum, heregulin peptide, forskolin, pituitary extract, penicillin/streptomycin and gentamycin (Schwann cells) or DMEM/F12 containing 10% fetal bovine serum (ARPE19 cells). Cultures were trypsinized, washed and delivered into the subretinal space through a small scleral incision as a suspension in 2 ll of DMEM alone (Schwann cells) or DMEM/ F12 (ARPE19 cells) using a fine glass pipette (internal diameter 75-150 lm) attached by tubing to a 10 ll Hamilton syringe. The cell suspensions contained about 2 · 10 5 ARPE19 cells, 2 · 10 4 Schwann cells and 2 · 10 4 fibroblasts, respectively. The cornea of the recipient eye was punctured to reduce intraocular pressure and to limit the efflux of cells. Immediately after injection, the fundus was examined to check for retinal damage or signs of vascular distress, and any animals showing such problems were removed from the study. Samples of donor cells were checked for viability at the beginning and end of a transplantation session using Trypan blue staining. A typical figure of greater than 95% intact cells was obtained at both time points. Sham animals received injection of carrier medium and were otherwise treated identically to the cell transplant groups.
Visual Water Task
The grating acuity of all animals was assessed using the Visual Water Task, which is a visual perception task that has been described in detail previously (McGill et al., 2004; Prusky, Lu, Douglas, & Lund, 2002; Prusky, West, & Douglas, 2000) . Briefly, the apparatus consisted of a trapezoidal-shaped pool with two computer monitors facing through a clear glass wall into the wide end of the pool and a midline divider extending into the pool from between the monitors, creating a Y-maze with a stem and two arms. Animals are trained to discriminate between different visual stimuli generated and projected on the screens using a computer program (Vista Ó ; CerebralMechanics).
Training and testing followed the same procedure as described elsewhere (McGill et al., 2004) except that animals in this study were tested once per month commencing at four months of age. ARPE19 transplanted and sham animals were tested up to seven months of age at the University of Lethbridge, at which point they were transported to the University of Utah for physiological and anatomical analyses (Sauvé, Lu, & Lund, 2003) . The Schwann cell and fibroblast transplanted animals were tested up to five months of age and then shipped to the University of Utah for further study (Wang, Lu, Wood, Lawrence, & Lund, 2003) . In order to collect correlative data at a stage when performance was optimal, post-surgical testing of the Schwann cell group was not extended to seven months of age.
Results
This study is built on the base of a previous study conducted under identical conditions on unoperated non-dystrophic and dystrophic RCS rats. In that study, Long-Evans rats were also examined to see whether non-dystrophic rats behaved similarly. The results showed that non-dystrophic RCS rats and Long-Evans rats performed identically with an average grating acuity slightly higher than 1.0 c/deg. By contrast, dystrophic rats at one month of age had an acuity of 0.82 c/deg and this fell to 0.32 c/deg by four months and showed a slower decline thereafter. A significant difference between that and the present work was that the animals were not maintained on cyclosporine. Comparison between the medium alone shams in the present experiment and the unoperated dystrophics of the previous study confirmed that this was not a significant factor (see Section 3.3).
Training
All rats readily learned to associate swimming to the platform with escape from the water. On average, about 150 trials (i.e. four-five days of testing) were required for animals to reach 90% accuracy over 40 trials and there were no obvious group differences in this ability.
Testing
During testing, all animals maintained a high level of performance at spatial frequencies below threshold and made very few, if any, errors. As the spatial frequencies neared threshold values, the animals made an increasing number of errors until performance dropped below 70%. Although the grating thresholds generally decreased with age, there was no evidence of any accompanying cognitive deficits, motor deficits, or lack of general ability to perform the task. All standard error values were less than 0.05. Fig. 1 displays frequency-of-seeing curves for a representative animal from each group at four Fig. 1 . Frequency of seeing curves used to calculate the acuity of an animal from each treatment group (ARPE19, vehicle, Schwann cells, and fibroblasts) on task performance at four months of age. Nondystrophic animals were tested at six months of age (McGill et al., 2004) . Arrows point to the thresholds calculated from each curve. A high level of performance was displayed at spatial frequencies below threshold for all animals. months of age. Note that although the thresholds differ between animals, the shapes of the functions are remarkably similar, indicating that an animalÕs performance in the task is not dependant upon acuity thresholds.
Sham controls
Eighteen animals were used as sham operated controls. These animals were tested from four to seven months of age, over which time the groupÕs average acuity dropped from 0.445 to 0.265 c/deg. An analysis of variance confirmed that the visual acuity of the sham animals decreased significantly with age (F (3,45) = 33.935, P = 0.000). The acuities of the sham animals followed the same degenerative profile over time as that of unoperated dystrophic animals (McGill et al., 2004) , and there was no significant difference (F (3,60) = 2.337, P = 0.083) between sham and unoperated animals from four to seven months of age. In comparison with non-dystrophic animals that sustained a visual acuity of around 1.0 c/ deg, the sham operated animals acuity was approximately half at four month and one quarter at seven months of age.
Fibroblast controls
Six animals were used as fibroblast controls. They were tested at four and five months of age. The average acuity of 0.46 c/deg at four months fell to 0.36 c/deg by five months of age. However, this change was not significant (F (1,11) = 3.968, P = 0.140) and the mean acuity of the fibroblast controls was indistinguishable from that of sham animals at four-five months.
ARPE19
The grating acuity of the 12 dystrophic RCS rats with ARPE19 cell transplants was tested from four to seven months of age. Transplanted animals exhibited an average visual acuity of 0.69 c/deg at four months, which fell to 0.38 c/deg by seven months. The best animals performed at 0.72 c/deg at four months and at five months gave a figure of 0.55 c/deg which is also the group mean. An analysis of variance was used to compare ARPE19 and sham operated control groups. There was a significant effect of age on ARPE19 transplantation (F (3,33) = 78.652, P = 0.000) and a significant age · treatment interaction (F (3,78) = 7.147, P = 0.000). Posthoc comparisons showed that ARPE19 transplanted animals had a higher acuity than sham controls at all ages. Fig. 2 shows the average grating acuity of the ARPE19 transplanted group compared with the sham transplanted animals at each age tested (four-seven months).
The mean acuity of the ARPE19 cell transplanted animals at four months of age was approximately 70% of non-dystrophic animals. This fell to about 40% of normal by seven months of age, with best performing animals showing figures of 0.82 and 0.46 c/deg at four and seven months respectively. However, the mean acuity of the transplant group was still approximately twice that of shams or unoperated controls (McGill et al., 2004) . In addition, the acuity of the best performing animals with ARPE19 cell transplants at four months of age was the same as unoperated dystrophic animals at one month of age.
Schwann cells
The grating acuities of the nine dystrophic RCS rats with Schwann cell transplants were tested at four and five months of age. The mean acuity of the group was 0.57 c/deg at four months of age, and this remained virtually unchanged at five months of age (0.55 c/deg; no significant effect of age F (1,8) = 1.561, P = 0.247). The two best performers gave figures of 0.72 c/deg and showed no significant deterioration between the two time points. An analysis of variance was used to compare Schwann cell transplant group with sham operated and fibroblast controls. There was no significant difference between the fibroblast group and the sham group (F (1,18) = 0.017, P = 0.898). There was a significant group effect of Schwann cells when compared with sham animals (F (1,23) = 10.738, P = 0.003) and with fibroblasts (F (1,11) = 6.017, P = 0.029), as well as a significant age · treatment interaction (F (1,11) = 5.153, P = 0.035). This indicated that the acuity of the Schwann cell group was significantly better than both control groups, even though the fibroblast group did not decrease significantly with age.
The mean acuity of the Schwann cell transplanted animals at both ages tested was approximately half that of normal non-dystrophic animals with the best animals performing better than 70% of non-dystrophics and 87% of one month old dystrophics (Fig. 3) .
Cell type comparison
Although the Schwann cell transplanted animals as a group had a mean acuity that was significantly better than both control groups (medium alone and fibroblasts), it was not as high as the ARPE19 transplants at four months of age. However, the best Schwann cell transplanted animals performed better than 0.70 c/deg and were able to sustain this level over the course of the next month; whereas the best ARPE19 animals also performed above 0.70 c/deg at four months but fell to 0.55 c/deg by five months of age. An analysis of variance was used to compare the ARPE19 and Schwann cell groups. The acuity of ARPE19 transplanted animals significantly decreased from four to five months of age (F (1,11) = 27.547, P < 0.000), whereas the Schwann cell group did not (F (1,8) = 1.561, P = 0.247). There was no significant group difference between Schwann cells and ARPE19 cells (F (1,19) = 1.875, P = 0.187) (Fig. 3) .
Discussion
The results of this study show that the Visual Water Task can be used in RCS rats to quantify the effects of cell transplantation on visual acuity over time. In addition, they show that the two cell types transplanted here, which had been shown previously to rescue photoreceptors, can also preserve spatial vision, in best cases to better than 70% of normal at four months of age. At all ages tested, ARPE19 and Schwann cell transplanted animals significantly outperformed controls. All animals, both transplanted and sham operated performed competently in the task even as their vision deteriorated, indicating that only threshold values, and not general behavioral proficiency, changed over time. Similarly, the treatment condition did not appear to affect the ability of animals to distinguish salient visual stimuli, signifying that the effects of cell transplantation can be directly evaluated.
It is clear that ARPE19 transplantation provided a significant benefit to vision. This builds on previous work showing that different RPE cells, either freshly harvested or using immortalized cell lines as used here, not only preserve photoreceptors but also visual responsiveness Lund et al., 2001) . A range of visual behaviors have been shown to be preserved by this treatment including parameters of the ERG response (Sauvé et al., 2003) and pupillary light reflex (Whiteley, Litchfield, Coffey, & Lund, 1996) as well as relative retinal sensitivity in the area of graft preservation (Sauve et al., 2002) single unit physiological responses in the visual cortex (Girman, Wang, et al., 2003) and head tracking to a rotating drum . No studies, however, have systematically measured visual perception. Some measures of visual function, such as ERG and head tracking, are not generally sustained for long periods, even though other methods such as cortical physiology show continued functional rescue. Previous ARPE19 transplant studies used a terrestrial two-choice test to measure visual function , which was only able to record visual thresholds up to 0.35 c/deg, which is a far lower threshold than can be measured in rats in a range of tests including the Visual Water Task. Although the terrestrial task was able to discriminate performance in grafted vs unoperated dystrophics, it failed to discriminate between grafted and non-dystrophic animals (Coffey, . In that study, tested animals were selected on superior performance in an initial screening; furthermore performance was not tested over an extended period against performance in controls. Here we tested all animals in the group, bearing in mind that some may have had inadequate transplants. The Visual Water Task, used here is a higher resolution test and has made it possible to identify small variances in performance among animals and groups: its ease of performance makes it preferable to other methods used for testing rat vision. This study adds further support to the possibility that ARPE19 transplantation may be a viable treatment for retinal degenerative disease, Fig. 3 . The visual acuity of each treatment group at four and five months of age. Both ARPE19 and Schwann cell transplantation resulted in a significant benefit to vision, although the pattern of the rescue differed. Standard error bars are included in the graph; however, they are smaller than the data point symbols. The star and dotted line indicates visual acuity of non-dystrophic RCS rats at six months of age which is data from McGill et al. (2004) . See text for details.
because not only does it sustain anatomical, physiological and basic functional measures of the visual system, but it preserves acuity in best cases at a level close to that recorded in non-dystrophic pigmented rats.
Previous work on Schwann cell transplantation in RCS rats (Lawrence et al., 2000 (Lawrence et al., , 2004 showed that the cells survived in the subretinal space, rescued photoreceptors, sustained visual threshold responses recorded from the superior colliculus, slowed the deterioration of head tracking and preserved the receptive field properties of cortical neurons (Girman, Wang, et al., 2003) . We now show here that visual acuity, measured in a visual perception task, is also improved over unoperated rats. This benefit is most likely related to the ability of Schwann cells to produce a range of neurotrophic factors, including CNTF, GDNF and BDNF, which are known to preserve photoreceptors when introduced into the eye (Neuberger & De Vries, 1993; Sendtner, Stockli, & Thoenen, 1992) , and as such serves as a cell-based growth factor delivery approach. Because there is always the possibility of some contamination with fibroblasts in the isolation procedure, a fibroblast control was an important step to rule out the possibility that these cells might responsible for at least some of the rescue.
Previous work using the Visual Water Task (McGill et al., 2004) has shown that adult non-dystrophic RCS rats have acuity thresholds around 1.0 c/deg, which is normal for standard pigmented laboratory rats (Prusky et al., 2002) . Other more cumbersome methods have found similar grating thresholds (Dean & Pope, 1981) but these methods are less suitable to the serial testing from an early age that is a central feature of our study. The acuity of unoperated dystrophic RCS rats, however, is not normal: at one month it is around 0.8 c/deg, and it deteriorates to 0.32 c/deg by four months. In the present study, it is remarkable that at four months the animals with the highest acuity in both the ARPE19 and Schwann cell transplanted groups was better than 0.7 c/deg. This is well above the average acuity of sham operated and fibroblast control animals, which degenerated over time with a pattern similar to that observed in unoperated dystrophic RCS rats (McGill et al., 2004) . It should be noted that animals were not prescreened prior to functional testing, and based on previous experience, may have included some in which the transplantation was unsuccessful. The delay between cessation of behavioral testing and anatomical evaluation made it difficult to define whether poor anatomical rescue was the result of deterioration with time or an inadequate transplant at the outset. With this uncertainty, detailed comparison between the two sorts of transplant is not justified. However, it can be presumed that the best animals represent the optimal circumstances and since both gave similar results for the best performers, this indicates that both cell types might give comparable results under optimal conditions. The Visual Water Task employs a two-choice visual discrimination pool using visual stimuli that have a luminance of approximately 36 cd/m 2 . These light levels are likely to saturate any functional rods and is most likely testing cone function, however, no quantitative measures of cone photoreceptor survival in the RCS rat has been done. Other work (Girman, Lu, & Lund, 2003) has shown that rods become dysfunctional early in the course of degeneration in RCS rats and that transplantation of either Schwann cells or ARPE19 cells fails to recover rod function even though it promotes rod survival: most important, the transplants did manage to limit the further deterioration of cone responsiveness. On the basis of this, both the control and transplanted rats would be relying on remaining cone vision for the responses and the differences seen between transplanted and control rats would reflect the relative population of remaining of cones. In the future, variations of the visual stimuli used in the Visual Water Task may be used to assess rod or cone function separately.
Although both donor cell types were effective in limiting the loss of spatial vision in this study, there was nevertheless a gradual deterioration of vision with time. Whether this reflected the inadequacy of cyclosporin as a complete immunosuppressant (Crafoord, Algvere, Kopp, & Seregard, 2000; Del Priore et al., 2003) or a physiological problem associated with other aspects of graft cell survival or its ability to sustain photoreceptor rescue is unclear and is the subject of ongoing studies.
For possible application clinically, the ARPE19 cell line may have an advantage in being homologous to the defective host RPE and therefore potentially capable of replacing a number of physiological functions. It does have the drawbacks in not being syngeneic to the recipient and therefore requiring some level of immunosuppression, and in the safety considerations that attend all cell lines. Schwann cells, however, do appear to survive without pathological manifestations in the subretinal space and they do have the advantage that they could be harvested from a peripheral nerve of a patient and introduced into the subretinal space of that same patient. In demonstrating in this study that human Schwann cells have benefit to vision not very different from ARPE19 cells in an animal model of retinal degenerative disease, it is clear that with the potential of performing autologous transplantation, the path from laboratory investigation is significantly simplified with this cell type.
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